AU2001251582A1 - Method and compositions for ordering restriction fragments - Google Patents

Method and compositions for ordering restriction fragments

Info

Publication number
AU2001251582A1
AU2001251582A1 AU2001251582A AU5158201A AU2001251582A1 AU 2001251582 A1 AU2001251582 A1 AU 2001251582A1 AU 2001251582 A AU2001251582 A AU 2001251582A AU 5158201 A AU5158201 A AU 5158201A AU 2001251582 A1 AU2001251582 A1 AU 2001251582A1
Authority
AU
Australia
Prior art keywords
compositions
restriction fragments
ordering restriction
ordering
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001251582A
Inventor
Stephen C. Macevicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lynx Therapeutics Inc
Original Assignee
Lynx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/549,748 external-priority patent/US6720179B1/en
Application filed by Lynx Therapeutics Inc filed Critical Lynx Therapeutics Inc
Publication of AU2001251582A1 publication Critical patent/AU2001251582A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
AU2001251582A 2000-04-14 2001-04-12 Method and compositions for ordering restriction fragments Abandoned AU2001251582A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09549748 2000-04-14
US09/549,748 US6720179B1 (en) 1998-02-23 2000-04-14 Method and compositions for ordering restriction fragments
PCT/US2001/011981 WO2001079553A1 (en) 2000-04-14 2001-04-12 Method and compositions for ordering restriction fragments

Publications (1)

Publication Number Publication Date
AU2001251582A1 true AU2001251582A1 (en) 2001-10-30

Family

ID=24194242

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001251582A Abandoned AU2001251582A1 (en) 2000-04-14 2001-04-12 Method and compositions for ordering restriction fragments

Country Status (2)

Country Link
AU (1) AU2001251582A1 (en)
WO (1) WO2001079553A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10145553B4 (en) * 2001-09-16 2006-06-08 Gene Architects Ag Nucleic acid for a cloning vector
EP2202322A1 (en) 2003-10-31 2010-06-30 AB Advanced Genetic Analysis Corporation Methods for producing a paired tag from a nucleic acid sequence and methods of use thereof
GB0514910D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Method for sequencing a polynucleotide template
GB0514935D0 (en) 2005-07-20 2005-08-24 Solexa Ltd Methods for sequencing a polynucleotide template
WO2007076726A1 (en) * 2006-01-04 2007-07-12 Si Lok Methods for nucleic acid mapping and identification of fine-structural-variations in nucleic acids and utilities
US8192930B2 (en) 2006-02-08 2012-06-05 Illumina Cambridge Limited Method for sequencing a polynucleotide template
US7754429B2 (en) 2006-10-06 2010-07-13 Illumina Cambridge Limited Method for pair-wise sequencing a plurity of target polynucleotides
US9540637B2 (en) 2008-01-09 2017-01-10 Life Technologies Corporation Nucleic acid adaptors and uses thereof
CN102016068A (en) 2008-01-09 2011-04-13 生命科技公司 Method of making a paired tag library for nucleic acid sequencing
CN102597256B (en) 2009-08-25 2014-12-03 伊鲁米那股份有限公司 Methods for selecting and amplifying polynucleotides
US20220316003A1 (en) 2020-03-09 2022-10-06 Illumina, Inc. Methods for sequencing polynucleotides
WO2023114394A1 (en) 2021-12-17 2023-06-22 Illumina, Inc. Orthogonal hybridization
WO2023175041A1 (en) 2022-03-15 2023-09-21 Illumina, Inc. Concurrent sequencing of forward and reverse complement strands on concatenated polynucleotides
WO2023175037A2 (en) 2022-03-15 2023-09-21 Illumina, Inc. Concurrent sequencing of forward and reverse complement strands on separate polynucleotides for methylation detection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995011971A1 (en) * 1993-10-28 1995-05-04 Life Technologies, Inc. Nucleic acid marker ladder for estimating mass
US5846719A (en) * 1994-10-13 1998-12-08 Lynx Therapeutics, Inc. Oligonucleotide tags for sorting and identification
US5804382A (en) * 1996-05-10 1998-09-08 Beth Israel Deaconess Medical Center, Inc. Methods for identifying differentially expressed genes and differences between genomic nucleic acid sequences
US6054276A (en) * 1998-02-23 2000-04-25 Macevicz; Stephen C. DNA restriction site mapping

Also Published As

Publication number Publication date
WO2001079553A1 (en) 2001-10-25

Similar Documents

Publication Publication Date Title
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001245437A1 (en) Lightweight methods and compositions for well treating
AU2001261566A1 (en) Well service composition and method
AU2002361623A1 (en) Methods and compositions for chromatography
EP1341864A4 (en) Method for making abrasive compositions and products thereof
AU2002346651A1 (en) Endorepellin compositions and methods for inhibiting angiogenesis
AU2001251582A1 (en) Method and compositions for ordering restriction fragments
AU2002364708A1 (en) Novel compositions and methods for cancer
EP1509539A4 (en) Novel compositions and methods for cancer
AU2002315066A1 (en) Methods for making antibody fragments and compositions resulting therefrom
AU2002357748A1 (en) Osteopontin-related compositions and methods
EP1469769A4 (en) Novel compositions and methods for cancer
GB0126643D0 (en) Composition and process
AU2001233932A1 (en) Method and composition
AU2001288736A1 (en) Method and composition for enhancing vision
IL158764A0 (en) Methods and compositions for making emamectin
AU2002337943A1 (en) Novel compositions and methods for cancer
AU2003295574A1 (en) Method and compositions for temporarily incapaciting subjets
EP1469870A4 (en) Novel compositions and methods for cancer
AU2002239775A1 (en) Chemical-library composition and method
AU2001283226A1 (en) Methods and compositions for inhibiting rad51
AU2001249194A1 (en) Immunokine composition and method
AU2002359869A1 (en) Pak5-related compositions and methods
AU2002342188A1 (en) Methods and compositions for treating flavivirus-mediated disease
AU2002246221A1 (en) Method and composition